Status:
COMPLETED
Treatment of Moderate to Severe Facial Acne Vulgaris
Lead Sponsor:
Warner Chilcott
Conditions:
Acne Vulgaris
Eligibility:
All Genders
12-45 years
Phase:
PHASE2
Brief Summary
Randomized, multi-center, double-blind, placebo-controlled 12-week study to assess the safety and efficacy of 3 doses of an oral formulation of Doxycycline oral tablets using the Investigator's Global...
Eligibility Criteria
Inclusion
- Must be between 12 and 45 years of age.
- Has a diagnosis of moderate to severe facial acne vulgaris with no more than two nodules on the face
Exclusion
- Is allergic to tetracycline-class antibiotics or to any ingredient in the study medication.
- Has a history of pseudomembranous colitis or antibiotic-associated colitis.
- Has a history of hepatitis or liver damage or renal impairment.
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
257 Patients enrolled
Trial Details
Trial ID
NCT00612573
Start Date
February 1 2008
End Date
December 1 2008
Last Update
April 22 2013
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Warner Chilcott Investigational Site
Encino, California, United States, 91436
2
Warner Chilcott Investigational Site
Fremont, California, United States, 94538
3
Warner Chilcott Investigational Site
Los Angeles, California, United States, 90045
4
Warner Chilcott Investigational Site
Sacramento, California, United States, 95816